NCT00427570View on ClinicalTrials.gov

Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1977

Study Completion Date

May 31, 2006

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

BCG vaccine

BIOLOGICAL

biological therapy

DRUG

fluorouracil

DRUG

semustine

DRUG

vincristine sulfate

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NSABP Foundation Inc

NETWORK

NCT00427570 - Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery | Biotech Hunter | Biotech Hunter